Randomized phase II study comparing cisplatin plus pemetrexed plus bevacizumab with carboplatin plus paclitaxel plus bevacizumab in treatment-naive advanced non-squamous non-small cell lung cancer (CLEAR study)

被引：0

作者：

Koyama, R. ^{[1
]}

Udagawa, H. ^{[2
]}

Sugiyama, E. ^{[3
]}

Komuta, K. ^{[4
]}

Mori, M. ^{[5
]}

Yokoyama, T. ^{[6
]}

Sasaki, T. ^{[7
]}

Saito, H. ^{[8
]}

Ishida, H. ^{[9
]}

Nakagawa, H. ^{[10
]}

Sekine, A. ^{[11
]}

Tamura, A. ^{[12
]}

Shingyoji, M. ^{[13
]}

Mizuno, K. ^{[14
]}

Nakamura, A. ^{[15
]}

Kinoshita, A. ^{[16
]}

Yamanaka, T. ^{[17
]}

Goto, K. ^{[2
]}

机构：

[1] Juntendo Univ, Fac Med, Dept Resp Med, Tokyo, Japan

[2] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan

[3] Natl Canc Ctr, Div Canc Immunol, Kashiwa, Chiba, Japan

[4] Osaka Police Hosp, Dept Resp Med, Osaka, Japan

[5] Natl Hosp Org Toneyama Natl Hosp, Dept Thorac Oncol, Toyonaka, Osaka, Japan

[6] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan

[7] Asahikawa Med Univ, Resp Ctr, Asahikawa, Hokkaido, Japan

[8] Kanagawa Canc Ctr, Dept Thorac Oncol, Yokohama, Kanagawa, Japan

[9] Showa Univ, Div Med Oncol, Sch Med, Tokyo, Japan

[10] Natl Hosp Org Hirosaki Hosp, Dept Resp Med, Hirosaki, Aomori, Japan

[11] Kanagawa Cardiovasc & Resp Ctr, Dept Resp Med, Yokohama, Kanagawa, Japan

[12] Natl Hosp Org Tokyo Natl Hosp, Ctr Pulm Dis, Tokyo, Japan

[13] Chiba Canc Ctr, Div Respirol, Chiba, Japan

[14] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pulm Med, Kagoshima, Japan

[15] Sendai Kousei Hosp, Dept Pulm Med, Sendai, Miyagi, Japan

[16] Nagasaki Prefecture Shimabara Hosp, Dept Resp Med, Shimabara, Japan

[17] Yokohama City Univ Med, Dept Biostat, Yokohama, Kanagawa, Japan

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1436P

引用

页数：1

共 50 条

[41] Phase II Trial of Carboplatin, Pemetrexed, Bevacizumab in Advanced non-Small Cell (non-Squamous) Lung Cancer
Guarino, Michael J.
Masters, Gregory A.
Biggs, David D.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S698 - S698
[42] BEVACIZUMAB (B), CISPLATIN (C) AND PEMETREXED (P) PLUS MAINTENANCE B IN CHEMO-NAiVE PATIENTS (PTS) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSNSCLC): A PHASE II STUDY
Lopez Vivanco, G.
Carrera Revilla, S.
Sancho Gutierrez, A.
Marrodan Ciordia, I.
Azkona Uribelarrea, E.
Iruarrizaga Ovejas, E.
Rubio Etxebarria, I.
Cardona, J. V.
Munoz Llerena, A.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S72 - S72
[43] First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naive patients
Leon, Luis
Vazquez, Sergio
Manuel Gracia, Jose
Casal, Joaquin
Lazaro, Martin
Luis Firvida, Jose
Amenedo, Margarita
Santome, Lucia
Macia, Sonia
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (10) : 1389 - 1396
[44] PHASE II STUDY OF BEVACIZUMAB IN COMBINATION WITH CARBOPLATIN PLUS PACLITAXEL AS FIRST-LINE CHEMOTHERAPY FOR NON-SQUAMOUS NON-SMALL CELL LUNG CANCER WITH MALIGNANT PLEURAL EFFUSION
Tamiya, Akihiro
Tamiya, Motohiro
Yamadori, Tadahiro
Yasue, Tomomi
Nakao, Keiko
Shiroyama, Takayuki
Asami, Kazuhiro
Morishita, Naoko
Suzuki, Hidekazu
Okamoto, Norio
Okishio, Kyoichi
Kawaguchi, Tomoya
Hirashima, Tomonori
Atagi, Shinji
[J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1159 - S1160
[45] The cost-effectiveness of bevacizumab plus cisplatin and gemcitabine (BCG) compared with pemetrexed plus cisplatin (PC) induction treatment of advanced non-squamous non-small cell lung cancer (NSCLC) in Germany.
Bischoff, H.
Hermes, A.
Gatzemeier, U.
Heigener, D. F.
Cesaro-Tadic, S.
Walzer, S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[46] Phase II study of bevacizumab in combination with carboplatin plus paclitaxel as first-line chemotherapy for non-squamous non-small cell lung cancer with malignant pleural effusion
Tamiya, M.
Tamiya, A.
Asami, K.
Okishio, K.
Kawagchi, T.
Suzuki, H.
Okamoto, N.
Kawase, I.
Atagi, S.
Hirashima, T.
[J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S826 - S826
[47] PHARMACOGENETIC STUDY OF JAPANESE PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER TREATED WITH PEMETREXED PLUS CISPLATIN
Imai, Hisao
Takahashi, Toshiaki
Serizawa, Masakuni
Mori, Keita
Ono, Akira
Akamatsu, Hiroaki
Taira, Tetsuhiko
Nakamura, Yukiko
Kenmotsu, Hirotsugu
Naito, Tateaki
Murakami, Haruyasu
Koh, Yasuhiro
Endo, Masahiro
Nakajima, Takashi
Yamamoto, Nobuyuki
[J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1077 - S1077
[48] An indirect comparison of the efficacy of bevacizumab plus cisplatin and gemcitabine (BCG) or bevacizumab plus carboplatin and paclitaxel (BCP) versus pemetrexed plus cisplatin (PC) and cetuximab plus vinorelbine and cisplatin (CVC) in patients (pts) with advanced or recurrent non-small cell cancer (NSCLC)
Walzer, S.
de Castro Carpeno, J.
Vergnenegre, A. V.
Chouaid, C.
Heigener, D. F. H.
Bischoff, H. G.
Nicolson, M. C.
Aultman, R.
Siebert, U.
[J]. EJC SUPPLEMENTS, 2009, 7 (02): : 555 - 555
[49] BEVACIZUMAB plus PACLITAXEL plus CARBOPLATIN (BEV plus PAC plus CAR) VS. PEMETREXED plus CISPLATIN (PEM plus CIS) IN ADENOCARCINOMA NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): A COST-EFFECTIVENESS ANALYSIS FROM A POLISH PUBLIC PAYER'S PERSPECTIVE
Kawalec, P.
Badurak, P.
Denisso, T.
Jastrzebski, D.
Marek, M.
Pluzanski, A.
Szczesna, A.
Szkultecka-Debek, M.
Russel-Szymczyk, M.
[J]. VALUE IN HEALTH, 2010, 13 (07) : A268 - A268
[50] A phase II study of carboplatin plus weekly paclitaxel with bevacizumab for elderly patients with non-squamous non-small-cell lung cancer (NEJ016)
Miura, Satoru
Maemondo, Makoto
Iwashima, Akira
Harada, Toshiyuki
Sugawara, Shunichi
Kobayashi, Kunihiko
Inoue, Akira
Nakagawa, Taku
Takiguchi, Yuichi
Watanabe, Hiroshi
Ishida, Takashi
Terada, Masaki
Kagamu, Hiroshi
Gemma, Akihiko
Yoshizawa, Hirohisa
[J]. INVESTIGATIONAL NEW DRUGS, 2017, 35 (02) : 227 - 234

← 1 2 3 4 5 →